This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mazoit, J. X. Articles by Froideveaux, R. Search for Related Content PubMed PubMed Citation Articles by Mazoit, J. X. Articles by Froideveaux, R.

Pharmacokinetics of Bupivacaine after Short and Prolonged Infusions in Conscious Dogs

Departments of Anesthesiology and Pharmacology, Université Paris-Sud, Hôpital Bicêtre, France.

Abstract

A conscious dog model was used to study pharmacokinetics of bupivacaine after a short infusion (SI) (15 min) and a prolonged infusion (PI) (24 hours). Bupivacaine was infused in six mongrel dogs at least 10 days after implantation of femoral arterial and venous catheters. Each dog received both the SI and the PI in a random crossover design at a one week interval. Bupivacaine concentration was measured in serum sampled during the SI, during the last hour of the PI, and at frequent intervals during eight hours after cessation of infusion. Indocyanine green (ICG) clearance also was measured during the last hour of the PI and 90 ruin after cessation of both the SI and the PI. The terminal half-life (T1/2_Z) of bupivacaine increased after the PI compared with the SI, 167 ± 86 vs 53 ± 13 min, respectively (mean ± SD; P < 0.05), and total body clearance (CI) decreased, 3.4 ± 1.2 vs 9.5 ± 4.5 ml min^–1 kg^–1, (P < 0.05), although the volumes of distribution (V_z and V_ss) did not change. A decrease in hepatic blood flow did not cause the decrease in CI because ICG clearance did not change during the three sets of measurements. Thus, the observed increase in T1/2_z and decrease in CI after the PI as compared with the SI are due to a decrease in hepatic intrinsic clearance of bupivacaine. Differences in the kinetic profile of the two enantiomers of bupivacaine cannot be excluded as a cause. We conclude that the extrapolation of kinetic data of bupivacaine obtained after a short infusion (or a bolus injection) to prolonged dosage must be done with care.

Key Words: PHARMACOKINETICS—local anesthetics bupivacaine. • ANESTHETICS, LOCAL—bupivacaine.

This article has been cited by other articles:

				Y. Oda, T. Funao, K. Tanaka, and A. Asada Vasodilation Increases the Threshold for Bupivacaine-Induced Convulsions in Rats Anesth. Analg., March 1, 2004; 98(3): 677 - 682. [Abstract] [Full Text] [PDF]

				L. Groban, D. D. Deal, J. C. Vernon, R. L. James, and J. Butterworth Cardiac Resuscitation After Incremental Overdosage with Lidocaine, Bupivacaine, Levobupivacaine, and Ropivacaine in Anesthetized Dogs Anesth. Analg., January 1, 2001; 92(1): 37 - 43. [Abstract] [Full Text] [PDF]